skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Some help for Paul asking for ideas to invest in his TFSA. In February (13)?, 2017, 5i answered a request for the top 10 picks harvested from the 5i portfolios. They were as follows: GSY, SHOP, SLF, WSP, GUD, OTEX, SIS, KXS, PBH, and one other I lost track of. Over the 4 years the return, if still held, would be +280%, but even without SHOP or GUD, the return is a respectable +96%. So for Paul and me would you do it again from current portfolio holdings. My New Years resolution is to pay more attention to your picks...........thx. Lionel
Read Answer Asked by Lionel on January 15, 2021
Q: Hi Team,
A couple different parts to this question. The "Geno" sector has exploded this year. Different hot names in the sector seem to be moving 10-20% daily. I have buddies now piling into these names now, so am wondering if maybey there's a "top" coming here soon? Or if you think this Euphoria will continue in the sector? To me it almost feels like gambling to try to buy in to these things right now. Also on this topic, can you briefly give your thoughts on what has made the Geno sector suddenly start to move this year? Its not like geno work is a new thing...or is it just hitting some major progress this year? Same can be said for the EV sector. For fear of "missing out" I am tempted to sell KXS out of my rsp for a slight gain as I hold this name in 2 different accounts to raise funds to buy EAGB (the canadian version of ARKG). My portfolio is currently heavy weighted tech and I currently have no Geno exposure. Is EAGB the best way for me to play this sector long term, or do you have any explosive individual GENO names you would recommend buying for a multi bagger possibility? I have heard BNGO has some good things coming its way? .....Or should I wait for a pullback in the massive run up before I think about doing this...or not at all? If I did buy EAGB I would probably buy and hold it for years as a way to play the sector. It does seem like there could be some major breakthroughs down the road in geno technology.
Read Answer Asked by Shane on January 15, 2021
Q: How does a Canadian investor become part of a new US issue. POSH IPO investors were able to garner over 100% return on the first day of trading but I'm not aware how to become part of a US IPO.

Thanks!
Adam
Read Answer Asked by Adam on January 15, 2021
Q: I would like a definition of a few words that are in the Asset Allocation & Other Statistics section of your portfolios, namely:
Active, upside capture of 2.40 vs 1, Down Semi-Std Dev. of 1.14% vs .60%.
I read the basic definitions in Investopedia and would like to know the relation between the data.
Read Answer Asked by Serge on January 15, 2021
Q: I hold a position in FCR.UN. that was part of a real estate trio in an income portfolio. The other  "partners" are TCN and BPY.UN which was recently sold for tax harvesting purposes.
The question now is should I sell FCR.UN which is just slightly in a loss position?
If the suggestion is to be patient and hold, what other one should I purchase as part of a real estate trio, aka to replace BPY.UN?........Thanks.......Tom
Read Answer Asked by Tom on January 15, 2021
Q: Regarding the preferred share offer. The option of 0.66 of BPYY is based on a par value of US$25 x 0.66 =$16.50. BPYY is currently trading at US$24.59 and has a 6.61%dividend. This effectively values BPY at US$16.23. So you have the choice of getting $16.23 for something worth $16.87 (all US) Please tell me if this calculation is correct.
Read Answer Asked by wayne on January 15, 2021
Q: I have depended upon NUANce's voice recognition software for twenty years. Good product & continuously improved with each iteration (now at Version 15). But as an investment it has been a dog -- bumping around the 10-20 USD range year after year. With no dividend to compensate. Until the pandemic. Since Mar 20 of this year the stock climbed from $14 and is now hitting $50, and still growing. One other point: their main software product, Dragon NaturallySpeaking (renamed Dragon Professional), was -- for nearly a decade -- priced at an MSRP of $150 USD. This month that price jumped instantly to $500 USD. Bam! My Question: Please offer your opinion about the prospects for this company as a worthy investment vehicle over the next few years. Thanks.
Read Answer Asked by RANDALL on January 15, 2021
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!